Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02071134 · ClinicalTrials.gov registry record

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

A clinical trial of Parkinson's Disease, sponsored by Boston Scientific Corporation.

Recruiting
Registry status
1,500
Enrollment target
20
Study locations

NCT02071134: Recruiting study of Parkinson's Disease, sponsored by Boston Scientific Corporation.

NCT02071134 is a study of Parkinson's Disease that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 1,500 participants, above the 626-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (140% higher). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02071134, a study of Parkinson's Disease, is actively recruiting participants, sponsored by Boston Scientific Corporation.

RECRUITING
Registry status
1,500 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease. The utilization of Image Guided Programming (IGP), and other commercially available programming features, used as planning tools for the programming of patients with Boston Scientific's Vercise DBS System are also evaluated. Additionally, the utilization of the DBS Illumina 3D feature that may be used for the programming of patients with Boston Scientific's Vercise DBS Systems is also evaluated.

Primary Outcome

Change in quality of life assessments during the study as compared with baseline

Conditions Studied

Parkinson's Disease

Interventions

  • DEVICE Deep Brain Stimulation (DBS)

Study Locations (20)

Florida

  • University of Florida Shands Hospital - Gainesville
  • Mayo Clinic, Jacksonville - Jacksonville
  • University of Miami Hospital - Miami
  • Tallahassee Neurological Clinic, PA - Tallahassee
  • University of South Florida - Tampa

New York

  • Albany Medical College - Albany
  • Northwell Health Neuroscience Institute - Great Neck
  • University at Buffalo - Williamsville

California

  • Neurology and Pain Specialty - Aliso Viejo
  • Cedars Sinai Medical Center - Los Angeles

Colorado

  • University of Colorado - Aurora
  • St. Mary's Hospital and Medical Center - Grand Junction

Ohio

  • Cleveland Clinic Foundation - Cleveland
  • Ohio State University - Columbus

Idaho

  • St. Luke Regional Medical Center - Boise

Illinois

  • Rush University Medical Center - Chicago

Indiana

  • Methodist Hospital of Indianapolis - Indianapolis

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2014-03-04
Est. Completion 2038-12
Boston Scientific Corporation

280 total trials

What NCT02071134 shows while recruiting

NCT02071134 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 626-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (140% higher).

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Deep Brain Stimulation (DBS) is the first listed.

NCT02071134 names 20 study sites across 11 states, led by Florida, New York, California.

Frequently Asked Questions

What is clinical trial NCT02071134 about?

NCT02071134 is a clinical study titled "Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry". The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease. The utilization of Image Guided Programming (IGP), and other commercially available programming fea...

What is the current status of trial NCT02071134?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2014-03-04. Estimated completion is 2038-12.

What conditions does trial NCT02071134 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT02071134?

The interventions under investigation include: Deep Brain Stimulation (DBS) (DEVICE).

Who is sponsoring clinical trial NCT02071134?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02071134 being conducted?

This trial has 20 study locations across California, Colorado, Florida, Idaho, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02071134's enrollment target sits among peer trials

1,500 9th of 158 higher than 150 of 158 other Parkinson's Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • NCT02677961 · 1,500 participants

    An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT02071134

Source: ClinicalTrials.gov NCT02071134, the US trial registry maintained by the National Library of Medicine. NCT02071134 (large enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.